| Table 1. Included studies characteristics. | |||||
| Author(s), Year | Number of Patients | Semen Collection and Analysis | COVID-19 in Semen | Seminal Quality Changes | Hormonal Changes |
|---|---|---|---|---|---|
| 30 men | Median time of 3 months after treatment and recovery | Not detected in any semen samples tested | ↓ Concentration and total number of spermatozoa; pH and normal volume | - | |
| 1st Sample: 41 men
|
Median time of 76.0 days after the appearance of symptoms and 56.0 days after hospital discharge | - | 27 men (65.9%): abnormal value for
at least one semen parameter.
|
Regular T, LH, FSH and AMH
|
|
| 29 men | The median duration between testing positive for SAR-CoV-2 and semen collection was 37 days | - | Volume,
|
Regular T, LH, FSH and Prolactin. | |
| 34 men | 18 semen samples were obtained 8-54 days after absence of symptoms, 14 from control subjects and 2 from patients with active COVID-19 infection. Not detected in recovered men or men with acute COVID-19 infection | Not detected in recovered men or men with acute COVID-19 infection. | ↓ Volume;
|
- | |
| Koç & Keseroğlu, 2021 | 21 men | None of the patients were in the active phase of COVID-19 at the time of semen collection | - | ↓ Volume;
|
↓ Testosterone
|
| 34 men | Median time of 31 days since COVID-19 diagnosis | Not detected in recovered patients | - | - | |
T: Testosterone; FSH: Follicle Stimulating Hormone; LH: Luteinizing Hormone; and AMH: Anti-Mullerian Hormone.